Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Apr 13;7(4):e014161.
doi: 10.1136/bmjopen-2016-014161.

Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation

Affiliations
Randomized Controlled Trial

Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation

Katie Finning et al. BMJ Open. .

Abstract

Objective: To explore participant views on acceptability, mechanisms of change and impact of behavioural activation (BA) delivered by junior mental health workers (MHWs) versus cognitive behavioural therapy (CBT) delivered by professional psychotherapists.

Design: Semistructured qualitative interviews analysed using a framework approach.

Participants: 36 participants with major depressive disorder purposively sampled from a randomised controlled trial of BA versus CBT (the COBRA trial).

Setting: Primary care psychological therapies services in Devon, Durham and Leeds, UK.

Results: Elements of therapy considered to be beneficial included its length and regularity, the opportunity to learn and not dwelling on the past. Homework was an important, although challenging aspect of treatment. Therapists were perceived as experts who played an important role in treatment. For some participants the most important element of therapy was having someone to talk to, but for others the specific factors associated with BA and CBT were crucial, with behavioural change considered important for participants in both treatments, and cognitive change unsurprisingly discussed more by those receiving CBT. Both therapies were considered to have a positive impact on symptoms of depression and other areas of life including feelings about themselves, self-care, work and relationships. Barriers to therapy included work, family life and emotional challenges. A subset (n=2) of BA participants commented that therapy felt too simple, and MHWs could be perceived as inexperienced. Many participants saw therapy as a learning experience, providing them with tools to take away, with work on relapse prevention essential.

Conclusions: Despite barriers for some participants, BA and CBT were perceived to have many benefits, to have brought about cognitive and behavioural change and to produce improvements in many domains of participants' lives. To optimise the delivery of BA, inexperienced junior MHWs should be supported through good quality training and ongoing supervision.

Trial registration number: ISRCTN27473954, 09/12/2011.

Keywords: Depression and mood disorders; Mental health; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors report grants from the UK National Institute for Health Research (NIHR) during the course of the study. DAR reports grants from the European Science Foundation. HAO’M reports grants from the UK Department of Health (DoH), Medical Research Council and Economic and Social Research Council and is an executive committee member of the BPS Perinatal Faculty and DoH Perinatal Clinical Reference Guideline. KAW is a clinical academic who teaches the theory and practice of BA and CBT.

Figures

Figure 1
Figure 1
Flow of participants through the study. *Recording equipment failed for one interview, leaving 36 available for analysis. BA, behavioural activation; CBT, cognitive behavioural therapy.

References

    1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498–504.10.1016/S0140-6736(96)07492-2 - DOI - PubMed
    1. Eaton WW, Shao H, Nestadt G, et al. . Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008;65:513–20.10.1001/archpsyc.65.5.513 - DOI - PMC - PubMed
    1. Kessler RC, Berglund P, Demler O, et al. ; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–105.10.1001/jama.289.23.3095 - DOI - PubMed
    1. Bloom DE, Cafiero ET, Jané-Llopis E, et al. . The global economic burden of noncommunicable diseases. Geneva: World Economic Forum, 2011.
    1. Amick HR, Gartlehner G, Gaynes BN, et al. . Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ 2015;351:h6019.10.1136/bmj.h6019 - DOI - PMC - PubMed

Publication types

Associated data